Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
If your post-PRP pain worsens, becomes unusual, or is accompanied by swelling, however, be sure to contact your healthcare provider
-Use of adequately large samples based on past research and statistical analysis
PMC4508379
WADA Prohibition The World Anti-Doping Agency classifies both peptides as prohibited substances: Both listed under Section S0 (Non-Approved Substances) Prohibited at all times (in and out of competition) No Therapeutic Use Exemptions (TUEs) available for either peptide Detection methods under development for anti-doping testing TB-500 and thymosin beta-4 explicitly banned since 2011 WADAs position reflects that neither peptide has regulatory approval from any health authority worldwide
The July 2026 Meeting: Approval Pathways Ahead The FDA has scheduled a July 2026 public meeting to explore formal approval pathways for these and similar peptides
The peptide has also been reported to interact with central dopaminergic and serotonergic axes: rodent behavioral studies describe effects on neuroplasticity, GABAergic tone, and stress response
